We're sorry, but this trial is no longer enrolling volunteers.
A Phase 1b/2 Study To Evaluate The Safety And Efficacy Of Pf-04449913, An Oral Hedgehog Inhibitor, In Combination With Intensive Chemotherapy, Low Dose Ara-c Or Decitabine In Patients With Acute Myeloid Leukemia Or High-risk Myelodysplastic Syndrome
Description
Phase
N/A
Inclusion and Exclusion Criteria
- Patients with AML or RAEB 2 High Risk MDS who are newly diagnosed according to the WHO 2008 Classification and previously untreated.
- Patients with AML (arising from an antecedent hematologic disease [AHD]) or MDS who may have had one prior regimen with commercially available agents for the treatment of their prior hematologic disease. The patients may not have had a prior therapy for their AML.
- AML patients include de novo AML, AML evolving from MDS or other AHD and AML after previous cytotoxic therapy or radiation (secondary AML)
- For a diagnosis of AML, a bone marrow blast count of 20% or more is required.
- For a diagnosis of high-risk Myelodysplastic Syndrome RAEB 2 the patient must have 10-19% bone marrow blasts
- Adequate Organ Function
- ECOG Performance Status 0, 1, or 2
- AML M3 Acute Promyelocytic Leukemia (APL) or patients with a t(9:22) cytogenetic translocation.
- Patients with known active uncontrolled central nervous system (CNS) leukemia.
Sites
-
California
- Pfizer Investigational Site, Los Angeles, California, 90095
- Pfizer Investigational Site, Carlsbad, California, 92008
- Pfizer Investigational Site, La Jolla, California, 92093
-
Washington
- Pfizer Investigational Site, Seattle, Washington, 98195
-
Kansas
- Pfizer Investigational Site, Kansas City, Kansas, 66160
- Pfizer Investigational Site, Westwood, Kansas, 66205
- Pfizer Investigational Site, Fairway, Kansas, 66205
-
Texas
- Pfizer Investigational Site, Houston, Texas, 77030
-
Missouri
- Pfizer Investigational Site, Creve Coeur, Missouri, 63141
- Pfizer Investigational Site, Saint Louis, Missouri, 63110
- Pfizer Investigational Site, St. Louis, Missouri, 63110
-
Illinois
- Pfizer Investigational Site, Chicago, Illinois, 60637
- Pfizer Investigational Site, Chicago, Illinois, 60611
-
Tennessee
- Pfizer Investigational Site, Nashville, Tennessee, 37203
-
Alabama
- Pfizer Investigational Site, Birmingham, Alabama, 35294
- Pfizer Investigational Site, Birmingham, Alabama, 35249
- Pfizer Investigational Site, Birmingham, Alabama, 35233
-
Indiana
- Pfizer Investigational Site, Indianapolis, Indiana, 46214
-
Germany
- Pfizer Investigational Site, Magdeburg, 39120
供电
SC CTSI